"As required by the bipartisan FDA Food Safety Modernization Act (FSMA), the U.S. Food and Drug Administration today proposed a rule that would require the largest food businesses in the United States and abroad to take steps to prevent facilities"...
- Patient Information:
INTRALIPID®20% IS METABOLIZED AND UTILIZED AS A SOURCE OF ENERGY CAUSING AN INCREASE IN HEAT PRODUCTION, DECREASE IN RESPIRATORY QUOTIENT AND INCREASE IN OXYGEN CONSUMPTION. THE INFUSED FAT PARTICLES ARE CLEARED FROM THE BLOOD STREAM IN A MANNER THOUGHT TO BE COMPARABLE TO THE CLEARING OF CHYLOMICRONS.
INTRALIPID® 20% (20% i.v. fat emulsion) WILL PREVENT THE BIOCHEMICAL LESIONS OF ESSENTIAL FATTY ACID DEFICIENCY (EFAD), AND CORRECT THE CLINICAL MANI-FESTATIONS OF THE EFAD SYNDROME.
Last reviewed on RxList: 7/30/2007
This monograph has been modified to include the generic and brand name in many instances.
Additional Intralipid 20% Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Weight Loss Wisdom
Get tips, recipes and inspiration.